title: Reduction in salivary cortisol concentration correlates with resolution of psychosis in Cushing's syndrome.
authors.forename: Paul C
authors.initials: PC
authors.lastname: Myhill
authors.forename: Brett A
authors.initials: BA
authors.lastname: Sillars
authors.forename: Sergio
authors.initials: S
authors.lastname: Starkstein
authors.forename: Tibor
authors.initials: T
authors.lastname: Annus
authors.forename: Bu B
authors.initials: BB
authors.lastname: Yeap
mesh_terms: D000963:Antimetabolites / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D012463:Saliva / Q000187:drug effects / Q000378:metabolism*; D013223:Statistics as Topic
chemical_list: D000963:Antimetabolites; D006854:Hydrocortisone; D008797:Metyrapone